SmartImmune provides clinical trials optimisation service to pharma and CROs, making cancer immunotherapies accessible and cost-efficient. We use the power of machine learning (AI) to design multi-dimensional biomarkers based on gene expression from cancer biopsy. Our AI is well-suited for clinical application as it is a tractable, ‘white box’ method that allows tracing the linkage between diagnosis, drugs and genes. Our proprietary technology enables:
- clinical trials (CT) optimisation
- precision medicine diagnostic tools